Codiak to Present Data from Two Novel Engineered Exosome Therapeutic Candidate Programs at the American Association for Cancer Research (AACR) Annual Meeting

NEXT STORY
Merus Announces Poster Presentations for Zenocutuzumab and MCLA-129 at the American Association for Cancer Research 2021 Annual Meeting
PREV STORY
Surface Oncology to Present Preclinical Data for Lead Product Programs at the American Association for Cancer Research Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis: forte performance au deuxième trimestre, soutenue par la dynamique des marques clés de croissance; prévisions pour l’exercice 2021 inchangées

author_avatar
NASDAQ Market News

Second Shipment of Dried Cannabis Materials Shipped to Pharmacy Australia Centre of Excellence by PreveCeutical’s Canadian Licensed Producer Partner for Novel Nose-to-Brain Drug Delivery Research

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces First Quarter 2018 Financial Results and Business Update Conference Call on May 30

COPENHAGEN, Denmark, May 16, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company ...

author_avatar
NASDAQ Market News